Business Context and Reporting Period
This Form 8-K is filed by Greatbatch, Inc. (not Integer Holdings Corp) on January 11, 2016. The filing announces the release of preliminary 2015 results and 2016 guidance in connection with the J.P. Morgan Healthcare Conference. The report focuses on historical pro forma information adjusted for the acquisition of Lake Region Medical Holdings, Inc. and the proposed spin-off of the QiG segment into Nuvectra Corporation.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the attached press release and investor presentations (Exhibits 99.1, 99.2, and 99.3), which are incorporated by reference but not included in the text of this 8-K.
The document defines the following non-GAAP measures used in the referenced materials:
- Adjusted Net Income/Adjusted EPS: GAAP amounts adjusted for acquisition charges, amortization, facility consolidation, asset write-downs, litigation, and tax items.
- Adjusted EBITDA: GAAP net income plus adjustments listed above, plus stock-based compensation, interest, depreciation, and amortization.
- Pro Forma Amounts: Historical or forecasted GAAP amounts adjusted for the Lake Region Medical acquisition, the Nuvectra spin-off, and related financing transactions.
Material Changes
The filing highlights two major structural changes affecting financial reporting:
- Acquisition: The Company acquired Lake Region Medical Holdings, Inc., resulting in a high level of indebtedness.
- Spin-off: The Company proposes to spin off a portion of its QiG segment, to be known as Nuvectra Corporation.
Reconciliations of non-GAAP measures to GAAP for 2015 preliminary results and 2016 guidance are not yet available in this filing.
Guidance, Outlook, and Risks
Guidance and Outlook: The Company has issued 2016 guidance and preliminary 2015 results, which include forward-looking statements regarding future sales and adjusted EBITDA. These statements are based on current expectations and are subject to risks and uncertainties.
Material Risks and Contingencies:
- Indebtedness: High levels of debt following the Lake Region Medical acquisition may limit financial flexibility and the ability to invest in the business.
- Spin-off Execution: Risks associated with the timing, taxable nature, and successful execution of the Nuvectra spin-off.
- Operational Risks: Dependence on a limited number of customers, pricing pressure, product obsolescence, and reliance on third-party suppliers.
- Regulatory and Legal: Pending regulatory approvals, healthcare reform, intellectual property challenges, and product liability claims.
Investor Verification Checklist
- Verify the specific numerical values for 2015 preliminary results and 2016 guidance in the attached Exhibits 99.1 and 99.2.
- Review the reconciliation of non-GAAP measures (Adjusted EBITDA, Adjusted Net Income) to GAAP once provided by the Company.
- Assess the impact of the Lake Region Medical acquisition on the Company's debt load and interest coverage.
- Monitor the progress and regulatory approval status of the proposed Nuvectra Corporation spin-off.
- Confirm the Company's ability to execute cost reduction and plant consolidation initiatives mentioned in the risk factors.